SlideShare a Scribd company logo
Dr SUNDEEP SALVI MD, DNB, PhD(UK)
CHEST RESEARCH FOUNDATION
Pune
WHY DO WE NEED A REFRESHER COURSE
ON OBSTRUCTIVE AIRWAYS DISEASES?
www.crfindia.com
LUNGS: THE ORGAN OF RESPIRATION
420 Lts of oxygen delivered every day
350 Lts of carbon dioxide removed every day
10,000 Lts air pass
in and out every 24
hours
10,000 Lts blood
pass every 24
hours
WHY DO WE NEED A REFRESHER
COURSE ON
OBSTRUCTIVE AIRWAYS DISEASES?
• Is OAD a major health problem in
India?
• A good history and a good clinical
examination are enough to diagnose
OAD. Or is it not?
• Are we not managing patients with
OAD better in our practice?
0
10000000
20000000
30000000
40000000
50000000
60000000
70000000
Cancer IHD Stroke Diabetes Chronic respiratory
disease
0.6 million
25 million
1 million
28 million
65 million
ESTIMATED MORBIDITY FOR NON COMMUNICABLE
DISEASES IN INDIA
(Nongkynrih B et al, JAPI 2004 Feb; 52: 118-123)
WHO, 2002 data
Asthma
COPD
0
5
10
15
20
25
30
35
ESTIMATED NUMBER OF OBSTRUCTIVE
AIRWAY DISEASE PATIENTS IN INDIA
Million
Asthma
COPD28 million
17 million
35 million
22.2 million
25% 30%
2006 2016
( Murthy KJR, NCMH Background Papers – Burden of Diseases in India, 2005 )
PREVALENCE OF ASTHMA IN SCHOOL
CHILDREN IN INDIA
(ISAAC STUDY)
(n = 15,621)
0
5
10
15
20
25
30
35
1979 1984 1989 1994 1999
Pune, Nagpur Bangalore
5 – 6%
Prevalence of asthma in Indian school children
varies from 2% - 30%
TOBACCO SMOKING
5- times more harmful
1 cigarette = 1 bidi
Not 15-20%, but close to 50% of smokers develop COPD
1 BILLION SMOKERS WORLD-WIDE
NON-SMOKING COPD
70% of Indian homes
50% of COPDs are non-smokers
3 BILLION PEOPLE WORLD-WIDE EXPOSED
0
1
2
3
4
5
6
7
8
Cancer IHD Stroke Diabetes Chronic Resp
diseases
Injuries
2.92
1.20
1.02
0.21
5.77
7.49
ESTIMATED MORTALITY FOR NON COMMUNICABLE
DISEASES IN INDIA
(Nongkynrih B et al, JAPI 2004 Feb; 52: 118-123)
WHO, 2002 data
Number in
lacs
0.0
0.5
1.0
1.5
2.0
2.5
3.0
Coronary
Heart
Disease
Stroke Other CVD COPD All Other
Causes
0.5
1.0
1.5
2.0
2.5
3.0
1965 - 1998 1965 - 1998 1965 - 1998 1965 - 1998 1965 - 1998
–59% –64% –35% +163% –7%
% change in Age-Adjusted Death
Rates, U.S.A., 1965-1998
OADs ARE A MAJOR AND
GROWING HEALTH BURDEN
IN INDIA?
UNIQUE SET OF RISK FACTORS FOR
OAD IN INDIA
HOW DO WE DIAGNOSE
OBSTRUCTIVE AIRWAYS DISEASES IN
CLINICAL PRACTICE?
HOW RELIABLE IS THIS?
UNDERDIAGNOSIS OF OLD IN OUT-PATIENT
CLINICS AND COMMUNITY SURVEYS
• American Study – NHANES III, >20,000 US
adults underwent spirometry (1988-1994)
Prevalence of OAD – 8.5%
63.3% under-diagnosis
(NHANES Study, Mannino et al, Arch Int Med 2000; 160: 1683-1689)
• Similar observations in UK, France, Spain and
other European countries
(Huchon, ERJ 2002; Pena, Am J Respir Crit Care Med 2001)
• More than 75% of patients with OAD have never
had a spirometry done in their life
• Spirometry is poorly utilized in India
• Myths about of Spirometry in India –
- Not really necessary for diagnosis of OAD
- Expensive test for the patients
- Difficult test to perform
- Difficult test to interpret
- Doesn’t make any difference in the management
of OAD
USE OF SPIROMETRY IN INDIA
HOW GOOD ARE WE AT
MANAGING ASTHMA AND COPD IN
CLINICAL PRACTICE?
• 420 cases of Obstructive Airways Disease
• 43.8% Asthma; 56.2% COPD
• Exacerbations - Daily: 52.6%
- Monthly: 31.2%
- < 1 mthly: 16.2%
• History of hospital admissions: 52%
• Usual treatment: - Antibiotics: 94.1%
- Oral theophylline: 93.1%
- Parenteral theophylline: 41.9%
- Salbutamol Inhaler: 81.2%
- Steroid Inhaler: 29.3%
- Oral steroids: 23.6%
EXPERIENCE OF OADs BY A CHEST
PHYSICIAN IN MUMBAI
(Kamat SR et al, Lung India, August 2006)
Tablet Salbutamol 2-4mg thrice daily
Versus
Inhaled Salbutamol 100-200mcg thrice daily
1000 excess tablets over a period of 6 months
0
10
20
30
40
50
60
UQMP QMP Specialist Institute
Use of pMDI by asthmatic subjects
(Rohtak, India)
Prescribed inhaler Correct use
(n = 1400)
(Gupta PP et al, Ind J Chest Dis Allied Sci 2001; 43: 91-95 )
%
(Chest Research Foundation and B.J. Medical College Pune, 2006)
DO MEDICAL PERSONNEL KNOW HOW TO USE
pMDI CORRECTLY?
1. Educate Patients
2. Assess and Monitor Severity
3. Avoid Exposure to Risk Factors
4. Establish Medication Plans for Chronic
Management: Adults and Children
5. Establish Plans for Managing Exacerbations
6. Provide Regular Follow-up Care
Six-Part Asthma Management
Program
0
2000
4000
6000
8000
10000
12000
14000
1995 2000 2005 2010 2015
Current If we follow guidelines
7641 crores
(Murthy KJR et al, NCMH Background Papers, 2005)
ECONOMIC BURDEN OF ASTHMA AND COPD
IN INDIA
0
5000
10000
15000
20000
25000
30000
35000
40000
45000
50000
25,209 crores
1996 2001 2006 2011 2016
SUMMARY
• Obstructive Airways Diseases are a major health
burden in India.
• The prevalence of OAD is only going to increase in
the future
• A large number of OADs remain undiagnosed in
clinical practice because of want of use of Spirometry
• Inhalation therapy is poorly used in India
• Patients suffering with OAD in India remain poorly
managed
• Doctors do not communicate effectively with patients
suffering with OADs
• OADs contribute to a huge economic loss in India
REFRESHER COURSE ON OBSTRUCTIVE AIRWAYS DISEASE

More Related Content

What's hot

Asthma conference final
Asthma conference finalAsthma conference final
Asthma conference final
Gregorio Cortes-Maisonet, MD, CHCP
 
Gina 2017-teaching-slide-set-full
Gina 2017-teaching-slide-set-fullGina 2017-teaching-slide-set-full
Gina 2017-teaching-slide-set-full
PHAM HUU THAI
 
Childhood asthma
Childhood asthmaChildhood asthma
Childhood asthma
Dr Pankaj Yadav
 
Pediatric Asthma
Pediatric AsthmaPediatric Asthma
Pediatric Asthma
Ashraf ElAdawy
 
Format 2016: tachypnoea in a well baby: what to do next?
Format 2016: tachypnoea in a well baby: what to do next?Format 2016: tachypnoea in a well baby: what to do next?
Format 2016: tachypnoea in a well baby: what to do next?
Envicon Medical Srl
 
Management of acute asthma or wheezing in pre-schoolers
Management of acute asthma or wheezing in pre-schoolersManagement of acute asthma or wheezing in pre-schoolers
Management of acute asthma or wheezing in pre-schoolers
Ashraf ElAdawy
 
Format 2016: how to get asthma control: from PubMed to the tricks of the trade.
Format 2016: how to get asthma control: from PubMed to the tricks of the trade.Format 2016: how to get asthma control: from PubMed to the tricks of the trade.
Format 2016: how to get asthma control: from PubMed to the tricks of the trade.
Envicon Medical Srl
 
Asthma a clinical review and its management
Asthma  a clinical review and its managementAsthma  a clinical review and its management
Asthma a clinical review and its management
Nani Karnam Vinayakam
 
1 whats-new-in-gina-2018 v1.2
1 whats-new-in-gina-2018 v1.21 whats-new-in-gina-2018 v1.2
1 whats-new-in-gina-2018 v1.2
Hiba Ashibany
 
Childhood asthma
Childhood asthmaChildhood asthma
Childhood asthma
Susheel Kumar Saini
 
Bronchial asthma clinical pharmacist hebatallah m abdallatif,bcps (1)
Bronchial asthma clinical pharmacist hebatallah m  abdallatif,bcps (1)Bronchial asthma clinical pharmacist hebatallah m  abdallatif,bcps (1)
Bronchial asthma clinical pharmacist hebatallah m abdallatif,bcps (1)
Heba Abd Allatif
 
GINA 2020 Guidelines for Asthma
GINA 2020 Guidelines for AsthmaGINA 2020 Guidelines for Asthma
GINA 2020 Guidelines for Asthma
mahimakura1
 
In acute loss of asthma contro always systemic steroidsoe add increase the do...
In acute loss of asthma contro always systemic steroidsoe add increase the do...In acute loss of asthma contro always systemic steroidsoe add increase the do...
In acute loss of asthma contro always systemic steroidsoe add increase the do...
Envicon Medical Srl
 
Childhood asthma - etiopathogenesis,clinical manifestations and evaluation
Childhood asthma - etiopathogenesis,clinical manifestations and evaluationChildhood asthma - etiopathogenesis,clinical manifestations and evaluation
Childhood asthma - etiopathogenesis,clinical manifestations and evaluation
Lokanath Reddy Mummadi
 
Management of Stable Asthma
Management of Stable AsthmaManagement of Stable Asthma
Management of Stable Asthma
Dr Subin Ahmed
 
GINA ASTHMA GUIDELINES UPDATE 2018
GINA ASTHMA GUIDELINES UPDATE 2018GINA ASTHMA GUIDELINES UPDATE 2018
GINA ASTHMA GUIDELINES UPDATE 2018
Mrinmoy ROY
 
Childhood asthma diagnosis and management
Childhood asthma diagnosis and managementChildhood asthma diagnosis and management
Childhood asthma diagnosis and management
Virendra Hindustani
 
Ashtma in children and young people - Pharmacological management
Ashtma in children and young people - Pharmacological managementAshtma in children and young people - Pharmacological management
Ashtma in children and young people - Pharmacological management
Ashraf ElAdawy
 

What's hot (20)

Asthma conference final
Asthma conference finalAsthma conference final
Asthma conference final
 
Gina 2017-teaching-slide-set-full
Gina 2017-teaching-slide-set-fullGina 2017-teaching-slide-set-full
Gina 2017-teaching-slide-set-full
 
Gina pocket 2014
Gina pocket 2014Gina pocket 2014
Gina pocket 2014
 
Childhood asthma
Childhood asthmaChildhood asthma
Childhood asthma
 
Pediatric Asthma
Pediatric AsthmaPediatric Asthma
Pediatric Asthma
 
Format 2016: tachypnoea in a well baby: what to do next?
Format 2016: tachypnoea in a well baby: what to do next?Format 2016: tachypnoea in a well baby: what to do next?
Format 2016: tachypnoea in a well baby: what to do next?
 
Case Study
Case Study Case Study
Case Study
 
Management of acute asthma or wheezing in pre-schoolers
Management of acute asthma or wheezing in pre-schoolersManagement of acute asthma or wheezing in pre-schoolers
Management of acute asthma or wheezing in pre-schoolers
 
Format 2016: how to get asthma control: from PubMed to the tricks of the trade.
Format 2016: how to get asthma control: from PubMed to the tricks of the trade.Format 2016: how to get asthma control: from PubMed to the tricks of the trade.
Format 2016: how to get asthma control: from PubMed to the tricks of the trade.
 
Asthma a clinical review and its management
Asthma  a clinical review and its managementAsthma  a clinical review and its management
Asthma a clinical review and its management
 
1 whats-new-in-gina-2018 v1.2
1 whats-new-in-gina-2018 v1.21 whats-new-in-gina-2018 v1.2
1 whats-new-in-gina-2018 v1.2
 
Childhood asthma
Childhood asthmaChildhood asthma
Childhood asthma
 
Bronchial asthma clinical pharmacist hebatallah m abdallatif,bcps (1)
Bronchial asthma clinical pharmacist hebatallah m  abdallatif,bcps (1)Bronchial asthma clinical pharmacist hebatallah m  abdallatif,bcps (1)
Bronchial asthma clinical pharmacist hebatallah m abdallatif,bcps (1)
 
GINA 2020 Guidelines for Asthma
GINA 2020 Guidelines for AsthmaGINA 2020 Guidelines for Asthma
GINA 2020 Guidelines for Asthma
 
In acute loss of asthma contro always systemic steroidsoe add increase the do...
In acute loss of asthma contro always systemic steroidsoe add increase the do...In acute loss of asthma contro always systemic steroidsoe add increase the do...
In acute loss of asthma contro always systemic steroidsoe add increase the do...
 
Childhood asthma - etiopathogenesis,clinical manifestations and evaluation
Childhood asthma - etiopathogenesis,clinical manifestations and evaluationChildhood asthma - etiopathogenesis,clinical manifestations and evaluation
Childhood asthma - etiopathogenesis,clinical manifestations and evaluation
 
Management of Stable Asthma
Management of Stable AsthmaManagement of Stable Asthma
Management of Stable Asthma
 
GINA ASTHMA GUIDELINES UPDATE 2018
GINA ASTHMA GUIDELINES UPDATE 2018GINA ASTHMA GUIDELINES UPDATE 2018
GINA ASTHMA GUIDELINES UPDATE 2018
 
Childhood asthma diagnosis and management
Childhood asthma diagnosis and managementChildhood asthma diagnosis and management
Childhood asthma diagnosis and management
 
Ashtma in children and young people - Pharmacological management
Ashtma in children and young people - Pharmacological managementAshtma in children and young people - Pharmacological management
Ashtma in children and young people - Pharmacological management
 

Similar to COPD Asthma Workshop

approach to stemi in non pci centre.pptx
approach to stemi in non pci centre.pptxapproach to stemi in non pci centre.pptx
approach to stemi in non pci centre.pptx
Shivani Rao
 
Update on the 18th International Conference on Co-morbidities and Adverse Dru...
Update on the 18th International Conference on Co-morbidities and Adverse Dru...Update on the 18th International Conference on Co-morbidities and Adverse Dru...
Update on the 18th International Conference on Co-morbidities and Adverse Dru...
UC San Diego AntiViral Research Center
 
Dr vijay pneumococcal disease prevention in older adults 2020
Dr vijay   pneumococcal disease prevention in older adults 2020Dr vijay   pneumococcal disease prevention in older adults 2020
Dr vijay pneumococcal disease prevention in older adults 2020
vkatbcd
 
Final FRD
Final FRDFinal FRD
Final FRD
Nina Shedd
 
A Study to Evaluate the Effectiveness of Planned Teaching Programme on Manage...
A Study to Evaluate the Effectiveness of Planned Teaching Programme on Manage...A Study to Evaluate the Effectiveness of Planned Teaching Programme on Manage...
A Study to Evaluate the Effectiveness of Planned Teaching Programme on Manage...
ijtsrd
 
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simba Takuva
 
Scleroderma Interstitial Lung Disease: What's New?
Scleroderma Interstitial Lung Disease: What's New?Scleroderma Interstitial Lung Disease: What's New?
Scleroderma Interstitial Lung Disease: What's New?
Scleroderma Foundation of Greater Chicago
 
Salon a 14 kasim 13.30 14.45 younsuck koh
Salon a 14 kasim 13.30 14.45 younsuck kohSalon a 14 kasim 13.30 14.45 younsuck koh
Salon a 14 kasim 13.30 14.45 younsuck koh
tyfngnc
 
Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...
Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...
Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...
hivlifeinfo
 
Advances in the diagnosis and treatment for benign and malignant thyroid disease
Advances in the diagnosis and treatment for benign and malignant thyroid diseaseAdvances in the diagnosis and treatment for benign and malignant thyroid disease
Advances in the diagnosis and treatment for benign and malignant thyroid disease
HealthXn
 
RespireRX: Biotech Showcase 2018 Slide Deck (PPT)
RespireRX: Biotech Showcase 2018 Slide Deck (PPT)RespireRX: Biotech Showcase 2018 Slide Deck (PPT)
RespireRX: Biotech Showcase 2018 Slide Deck (PPT)
RespireRX
 
5th Annual Early Age Onset Colorectal Cancer - Session V: Part II
5th Annual Early Age Onset Colorectal Cancer - Session V: Part II5th Annual Early Age Onset Colorectal Cancer - Session V: Part II
5th Annual Early Age Onset Colorectal Cancer - Session V: Part II
Colon Cancer Challenge Foundation
 
Sepsis 2016
Sepsis 2016 Sepsis 2016
Sepsis 2016
Subhankar Chatterjee
 
EPOC MAIN GUIDE GOLD 2016
EPOC MAIN GUIDE GOLD 2016EPOC MAIN GUIDE GOLD 2016
EPOC MAIN GUIDE GOLD 2016
Miguel Andres Paredes Cochachin
 
Severe Community Acquired Pneumonia (SCAP)
Severe Community Acquired Pneumonia (SCAP)Severe Community Acquired Pneumonia (SCAP)
Severe Community Acquired Pneumonia (SCAP)
Apollo Hospitals
 
Using primary care databases to evaluate drug benefits and harms: are the res...
Using primary care databases to evaluate drug benefits and harms: are the res...Using primary care databases to evaluate drug benefits and harms: are the res...
Using primary care databases to evaluate drug benefits and harms: are the res...
David Springate
 
GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf
GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdfGOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf
GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf
CarlosCastroCallirgo
 
99th publication sjmps- 3rd name
99th publication  sjmps- 3rd name99th publication  sjmps- 3rd name
99th publication sjmps- 3rd name
CLOVE Dental OMNI Hospitals Andhra Hospital
 
Genetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptx
Genetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptxGenetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptx
Genetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptx
Genetic Edge Compounds
 

Similar to COPD Asthma Workshop (20)

approach to stemi in non pci centre.pptx
approach to stemi in non pci centre.pptxapproach to stemi in non pci centre.pptx
approach to stemi in non pci centre.pptx
 
Wesat2203
Wesat2203Wesat2203
Wesat2203
 
Update on the 18th International Conference on Co-morbidities and Adverse Dru...
Update on the 18th International Conference on Co-morbidities and Adverse Dru...Update on the 18th International Conference on Co-morbidities and Adverse Dru...
Update on the 18th International Conference on Co-morbidities and Adverse Dru...
 
Dr vijay pneumococcal disease prevention in older adults 2020
Dr vijay   pneumococcal disease prevention in older adults 2020Dr vijay   pneumococcal disease prevention in older adults 2020
Dr vijay pneumococcal disease prevention in older adults 2020
 
Final FRD
Final FRDFinal FRD
Final FRD
 
A Study to Evaluate the Effectiveness of Planned Teaching Programme on Manage...
A Study to Evaluate the Effectiveness of Planned Teaching Programme on Manage...A Study to Evaluate the Effectiveness of Planned Teaching Programme on Manage...
A Study to Evaluate the Effectiveness of Planned Teaching Programme on Manage...
 
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
 
Scleroderma Interstitial Lung Disease: What's New?
Scleroderma Interstitial Lung Disease: What's New?Scleroderma Interstitial Lung Disease: What's New?
Scleroderma Interstitial Lung Disease: What's New?
 
Salon a 14 kasim 13.30 14.45 younsuck koh
Salon a 14 kasim 13.30 14.45 younsuck kohSalon a 14 kasim 13.30 14.45 younsuck koh
Salon a 14 kasim 13.30 14.45 younsuck koh
 
Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...
Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...
Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...
 
Advances in the diagnosis and treatment for benign and malignant thyroid disease
Advances in the diagnosis and treatment for benign and malignant thyroid diseaseAdvances in the diagnosis and treatment for benign and malignant thyroid disease
Advances in the diagnosis and treatment for benign and malignant thyroid disease
 
RespireRX: Biotech Showcase 2018 Slide Deck (PPT)
RespireRX: Biotech Showcase 2018 Slide Deck (PPT)RespireRX: Biotech Showcase 2018 Slide Deck (PPT)
RespireRX: Biotech Showcase 2018 Slide Deck (PPT)
 
5th Annual Early Age Onset Colorectal Cancer - Session V: Part II
5th Annual Early Age Onset Colorectal Cancer - Session V: Part II5th Annual Early Age Onset Colorectal Cancer - Session V: Part II
5th Annual Early Age Onset Colorectal Cancer - Session V: Part II
 
Sepsis 2016
Sepsis 2016 Sepsis 2016
Sepsis 2016
 
EPOC MAIN GUIDE GOLD 2016
EPOC MAIN GUIDE GOLD 2016EPOC MAIN GUIDE GOLD 2016
EPOC MAIN GUIDE GOLD 2016
 
Severe Community Acquired Pneumonia (SCAP)
Severe Community Acquired Pneumonia (SCAP)Severe Community Acquired Pneumonia (SCAP)
Severe Community Acquired Pneumonia (SCAP)
 
Using primary care databases to evaluate drug benefits and harms: are the res...
Using primary care databases to evaluate drug benefits and harms: are the res...Using primary care databases to evaluate drug benefits and harms: are the res...
Using primary care databases to evaluate drug benefits and harms: are the res...
 
GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf
GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdfGOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf
GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf
 
99th publication sjmps- 3rd name
99th publication  sjmps- 3rd name99th publication  sjmps- 3rd name
99th publication sjmps- 3rd name
 
Genetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptx
Genetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptxGenetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptx
Genetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptx
 

More from Jitendra Ingole

Hepatitis acute
Hepatitis acute Hepatitis acute
Hepatitis acute
Jitendra Ingole
 
Dysfunctional Uterine Bleeding (DUB)
Dysfunctional Uterine Bleeding (DUB)Dysfunctional Uterine Bleeding (DUB)
Dysfunctional Uterine Bleeding (DUB)
Jitendra Ingole
 
Doctor as detective
Doctor as detectiveDoctor as detective
Doctor as detective
Jitendra Ingole
 
Collection of blood for investigation met microteaching ppt
Collection of blood for investigation met microteaching pptCollection of blood for investigation met microteaching ppt
Collection of blood for investigation met microteaching ppt
Jitendra Ingole
 
Diabetes & high cholesterol _ Dr Ingole
Diabetes & high cholesterol _ Dr IngoleDiabetes & high cholesterol _ Dr Ingole
Diabetes & high cholesterol _ Dr Ingole
Jitendra Ingole
 
Dr Ingole_hypertension treatment concepts ,.,
Dr Ingole_hypertension treatment concepts ,.,Dr Ingole_hypertension treatment concepts ,.,
Dr Ingole_hypertension treatment concepts ,.,
Jitendra Ingole
 
Epilepsy and pregnancy ..,,
Epilepsy and pregnancy ..,, Epilepsy and pregnancy ..,,
Epilepsy and pregnancy ..,,
Jitendra Ingole
 
Subtle signs of myocardial ischaemia on ecg
Subtle signs of myocardial ischaemia on ecgSubtle signs of myocardial ischaemia on ecg
Subtle signs of myocardial ischaemia on ecg
Jitendra Ingole
 
Diplopia
DiplopiaDiplopia
Diplopia
Jitendra Ingole
 
Bleeding in early pregnancy
Bleeding in early pregnancyBleeding in early pregnancy
Bleeding in early pregnancyJitendra Ingole
 
Abortion
AbortionAbortion
Abortion
Jitendra Ingole
 
Abnormal cytology & histology of cervix _ Histopathology
Abnormal cytology & histology of cervix _ Histopathology Abnormal cytology & histology of cervix _ Histopathology
Abnormal cytology & histology of cervix _ Histopathology
Jitendra Ingole
 
Water and you-manthena raju
Water and you-manthena rajuWater and you-manthena raju
Water and you-manthena raju
Jitendra Ingole
 
Manthena raju a proven cure diabetes
  Manthena raju  a proven cure diabetes  Manthena raju  a proven cure diabetes
Manthena raju a proven cure diabetesJitendra Ingole
 

More from Jitendra Ingole (20)

Hepatitis acute
Hepatitis acute Hepatitis acute
Hepatitis acute
 
Dysfunctional Uterine Bleeding (DUB)
Dysfunctional Uterine Bleeding (DUB)Dysfunctional Uterine Bleeding (DUB)
Dysfunctional Uterine Bleeding (DUB)
 
Doctor as detective
Doctor as detectiveDoctor as detective
Doctor as detective
 
Collection of blood for investigation met microteaching ppt
Collection of blood for investigation met microteaching pptCollection of blood for investigation met microteaching ppt
Collection of blood for investigation met microteaching ppt
 
Diabetes & high cholesterol _ Dr Ingole
Diabetes & high cholesterol _ Dr IngoleDiabetes & high cholesterol _ Dr Ingole
Diabetes & high cholesterol _ Dr Ingole
 
Dr Ingole_hypertension treatment concepts ,.,
Dr Ingole_hypertension treatment concepts ,.,Dr Ingole_hypertension treatment concepts ,.,
Dr Ingole_hypertension treatment concepts ,.,
 
Epilepsy and pregnancy ..,,
Epilepsy and pregnancy ..,, Epilepsy and pregnancy ..,,
Epilepsy and pregnancy ..,,
 
Subtle signs of myocardial ischaemia on ecg
Subtle signs of myocardial ischaemia on ecgSubtle signs of myocardial ischaemia on ecg
Subtle signs of myocardial ischaemia on ecg
 
Diplopia
DiplopiaDiplopia
Diplopia
 
Pcos
PcosPcos
Pcos
 
Iugr (1)
Iugr (1)Iugr (1)
Iugr (1)
 
Uterine anomalies
Uterine anomaliesUterine anomalies
Uterine anomalies
 
Caesarean section
Caesarean sectionCaesarean section
Caesarean section
 
Bleeding in early pregnancy
Bleeding in early pregnancyBleeding in early pregnancy
Bleeding in early pregnancy
 
Amenorrhoea Amenorhhea
Amenorrhoea AmenorhheaAmenorrhoea Amenorhhea
Amenorrhoea Amenorhhea
 
Abortion
AbortionAbortion
Abortion
 
Abnormal cytology & histology of cervix _ Histopathology
Abnormal cytology & histology of cervix _ Histopathology Abnormal cytology & histology of cervix _ Histopathology
Abnormal cytology & histology of cervix _ Histopathology
 
Water and you-manthena raju
Water and you-manthena rajuWater and you-manthena raju
Water and you-manthena raju
 
Doctor as detective new
Doctor as detective newDoctor as detective new
Doctor as detective new
 
Manthena raju a proven cure diabetes
  Manthena raju  a proven cure diabetes  Manthena raju  a proven cure diabetes
Manthena raju a proven cure diabetes
 

Recently uploaded

How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 

Recently uploaded (20)

How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 

COPD Asthma Workshop

  • 1. Dr SUNDEEP SALVI MD, DNB, PhD(UK) CHEST RESEARCH FOUNDATION Pune WHY DO WE NEED A REFRESHER COURSE ON OBSTRUCTIVE AIRWAYS DISEASES? www.crfindia.com
  • 2. LUNGS: THE ORGAN OF RESPIRATION 420 Lts of oxygen delivered every day 350 Lts of carbon dioxide removed every day 10,000 Lts air pass in and out every 24 hours 10,000 Lts blood pass every 24 hours
  • 3. WHY DO WE NEED A REFRESHER COURSE ON OBSTRUCTIVE AIRWAYS DISEASES? • Is OAD a major health problem in India? • A good history and a good clinical examination are enough to diagnose OAD. Or is it not? • Are we not managing patients with OAD better in our practice?
  • 4. 0 10000000 20000000 30000000 40000000 50000000 60000000 70000000 Cancer IHD Stroke Diabetes Chronic respiratory disease 0.6 million 25 million 1 million 28 million 65 million ESTIMATED MORBIDITY FOR NON COMMUNICABLE DISEASES IN INDIA (Nongkynrih B et al, JAPI 2004 Feb; 52: 118-123) WHO, 2002 data Asthma COPD
  • 5. 0 5 10 15 20 25 30 35 ESTIMATED NUMBER OF OBSTRUCTIVE AIRWAY DISEASE PATIENTS IN INDIA Million Asthma COPD28 million 17 million 35 million 22.2 million 25% 30% 2006 2016 ( Murthy KJR, NCMH Background Papers – Burden of Diseases in India, 2005 )
  • 6. PREVALENCE OF ASTHMA IN SCHOOL CHILDREN IN INDIA (ISAAC STUDY) (n = 15,621) 0 5 10 15 20 25 30 35 1979 1984 1989 1994 1999 Pune, Nagpur Bangalore 5 – 6% Prevalence of asthma in Indian school children varies from 2% - 30%
  • 7. TOBACCO SMOKING 5- times more harmful 1 cigarette = 1 bidi Not 15-20%, but close to 50% of smokers develop COPD 1 BILLION SMOKERS WORLD-WIDE
  • 8. NON-SMOKING COPD 70% of Indian homes 50% of COPDs are non-smokers 3 BILLION PEOPLE WORLD-WIDE EXPOSED
  • 9. 0 1 2 3 4 5 6 7 8 Cancer IHD Stroke Diabetes Chronic Resp diseases Injuries 2.92 1.20 1.02 0.21 5.77 7.49 ESTIMATED MORTALITY FOR NON COMMUNICABLE DISEASES IN INDIA (Nongkynrih B et al, JAPI 2004 Feb; 52: 118-123) WHO, 2002 data Number in lacs
  • 10. 0.0 0.5 1.0 1.5 2.0 2.5 3.0 Coronary Heart Disease Stroke Other CVD COPD All Other Causes 0.5 1.0 1.5 2.0 2.5 3.0 1965 - 1998 1965 - 1998 1965 - 1998 1965 - 1998 1965 - 1998 –59% –64% –35% +163% –7% % change in Age-Adjusted Death Rates, U.S.A., 1965-1998
  • 11. OADs ARE A MAJOR AND GROWING HEALTH BURDEN IN INDIA?
  • 12. UNIQUE SET OF RISK FACTORS FOR OAD IN INDIA
  • 13. HOW DO WE DIAGNOSE OBSTRUCTIVE AIRWAYS DISEASES IN CLINICAL PRACTICE? HOW RELIABLE IS THIS?
  • 14. UNDERDIAGNOSIS OF OLD IN OUT-PATIENT CLINICS AND COMMUNITY SURVEYS • American Study – NHANES III, >20,000 US adults underwent spirometry (1988-1994) Prevalence of OAD – 8.5% 63.3% under-diagnosis (NHANES Study, Mannino et al, Arch Int Med 2000; 160: 1683-1689) • Similar observations in UK, France, Spain and other European countries (Huchon, ERJ 2002; Pena, Am J Respir Crit Care Med 2001)
  • 15. • More than 75% of patients with OAD have never had a spirometry done in their life • Spirometry is poorly utilized in India • Myths about of Spirometry in India – - Not really necessary for diagnosis of OAD - Expensive test for the patients - Difficult test to perform - Difficult test to interpret - Doesn’t make any difference in the management of OAD USE OF SPIROMETRY IN INDIA
  • 16. HOW GOOD ARE WE AT MANAGING ASTHMA AND COPD IN CLINICAL PRACTICE?
  • 17. • 420 cases of Obstructive Airways Disease • 43.8% Asthma; 56.2% COPD • Exacerbations - Daily: 52.6% - Monthly: 31.2% - < 1 mthly: 16.2% • History of hospital admissions: 52% • Usual treatment: - Antibiotics: 94.1% - Oral theophylline: 93.1% - Parenteral theophylline: 41.9% - Salbutamol Inhaler: 81.2% - Steroid Inhaler: 29.3% - Oral steroids: 23.6% EXPERIENCE OF OADs BY A CHEST PHYSICIAN IN MUMBAI (Kamat SR et al, Lung India, August 2006)
  • 18. Tablet Salbutamol 2-4mg thrice daily Versus Inhaled Salbutamol 100-200mcg thrice daily 1000 excess tablets over a period of 6 months
  • 19. 0 10 20 30 40 50 60 UQMP QMP Specialist Institute Use of pMDI by asthmatic subjects (Rohtak, India) Prescribed inhaler Correct use (n = 1400) (Gupta PP et al, Ind J Chest Dis Allied Sci 2001; 43: 91-95 ) %
  • 20. (Chest Research Foundation and B.J. Medical College Pune, 2006) DO MEDICAL PERSONNEL KNOW HOW TO USE pMDI CORRECTLY?
  • 21. 1. Educate Patients 2. Assess and Monitor Severity 3. Avoid Exposure to Risk Factors 4. Establish Medication Plans for Chronic Management: Adults and Children 5. Establish Plans for Managing Exacerbations 6. Provide Regular Follow-up Care Six-Part Asthma Management Program
  • 22. 0 2000 4000 6000 8000 10000 12000 14000 1995 2000 2005 2010 2015 Current If we follow guidelines 7641 crores (Murthy KJR et al, NCMH Background Papers, 2005) ECONOMIC BURDEN OF ASTHMA AND COPD IN INDIA 0 5000 10000 15000 20000 25000 30000 35000 40000 45000 50000 25,209 crores 1996 2001 2006 2011 2016
  • 23. SUMMARY • Obstructive Airways Diseases are a major health burden in India. • The prevalence of OAD is only going to increase in the future • A large number of OADs remain undiagnosed in clinical practice because of want of use of Spirometry • Inhalation therapy is poorly used in India • Patients suffering with OAD in India remain poorly managed • Doctors do not communicate effectively with patients suffering with OADs • OADs contribute to a huge economic loss in India
  • 24. REFRESHER COURSE ON OBSTRUCTIVE AIRWAYS DISEASE